发明名称 |
Enhanced erythropoiesis and iron metabolism |
摘要 |
The present invention relates to methods for treating anemia in a subject having a low percent transferrin saturation by administering to the subject an effective amount of a compound that inhibits hypoxia-inducible factor prolyl hydroxylase activity. |
申请公布号 |
US8604013(B2) |
申请公布日期 |
2013.12.10 |
申请号 |
US20100804042 |
申请日期 |
2010.07.12 |
申请人 |
KLAUS STEPHEN J.;MOLINEAUX CHRISTOPHER J.;NEFF THOMAS B.;GUENZLER-PUKALL VOLKMAR;LANGSETMO PAROBOK INGRID;SEELEY TODD W.;STEPHENSON ROBERT C.;FIBROGEN, INC. |
发明人 |
KLAUS STEPHEN J.;MOLINEAUX CHRISTOPHER J.;NEFF THOMAS B.;GUENZLER-PUKALL VOLKMAR;LANGSETMO PAROBOK INGRID;SEELEY TODD W.;STEPHENSON ROBERT C. |
分类号 |
A01N43/00;A61K31/00;A61K31/165;A61K31/33;A61K31/395;A61P7/06 |
主分类号 |
A01N43/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|